Skip to main content
  • Contact
  • Glossary
  • Subscribe
  • Search

PATH's Malaria Vaccine Initiative

Accelerating Malaria Vaccine Development

  • Malaria vaccines & biologics
    • Need for vaccines
      • Malaria vaccine roadmap
      • Preferred product characteristics
    • Malaria parasite life cycle
  • R&D
    • First-generation vaccines
    • Next-generation vaccines
      • Pre-erythrocytic vaccine candidates
      • Blood-stage vaccine candidates
      • Transmission-blocking vaccine candidates
      • Combination vaccine candidates
    • Monoclonal antibodies
  • RTS,S
    • Piloting RTS,S
      • Cost of delivering RTS,S
      • Public health impact and cost-effectiveness
      • Qualitative study on vaccine use
      • Case control studies
    • Clinical trial history of RTS,S
      • RTS,S use in seasonal settings
    • Expanded use of RTS,S
  • Access
    • Preparing for malaria vaccine decisions
      • Global policy and regulatory pathways
      • Decision-making framework
        • The decision-making framework for malaria vaccines
        • Economic analysis
        • Public health impact analysis
        • Sociocultural research
    • Financing
  • Resources
    • Search all resources
    • Fact sheets
    • Journal articles
    • Publications
    • Videos
    • Reports
    • Past projects
  • News
    • Press releases
    • Perspectives
  • About us
    • Donors
    • Contact us
  • Work with us
    • RFPs
    • Advocacy
      • Malaria Vaccine Advocacy Fellowship
      • Tools for advocates
    • Propose a project
  • Malaria vaccines & biologics
    • Need for vaccines
      • Malaria vaccine roadmap
      • Preferred product characteristics
    • Malaria parasite life cycle
  • R&D
    • First-generation vaccines
    • Next-generation vaccines
      • Pre-erythrocytic vaccine candidates
      • Blood-stage vaccine candidates
      • Transmission-blocking vaccine candidates
      • Combination vaccine candidates
    • Monoclonal antibodies
  • RTS,S
    • Piloting RTS,S
      • Cost of delivering RTS,S
      • Public health impact and cost-effectiveness
      • Qualitative study on vaccine use
      • Case control studies
    • Clinical trial history of RTS,S
      • RTS,S use in seasonal settings
    • Expanded use of RTS,S
  • Access
    • Preparing for malaria vaccine decisions
      • Global policy and regulatory pathways
      • Decision-making framework
    • Financing
  • Resources
    • Search all resources
    • Fact sheets
    • Journal articles
    • Publications
    • Videos
    • Reports
    • Past projects
  • News
    • Press releases
    • Perspectives
  • About us
    • Donors
    • Contact us
  • Work with us
    • RFPs
    • Advocacy
      • Malaria Vaccine Advocacy Fellowship
      • Tools for advocates
    • Propose a project
  • Home
  • Resources
  • Fact sheets
  • Fact sheets

Fact sheets

Displaying 1 - 8 of 20

The RTS,S Malaria Vaccine: First Malaria Vaccine Recommended by the WHO for Children at Risk

Published 26 April 2023
Fact sheet

Frequently Asked Questions (FAQs): RTS,S/AS01 for seasonal use

Published 25 August 2021
Fact sheet

Frequently Asked Questions (FAQs): Product Transfer for the RTS,S/AS01 Malaria Vaccine

Published 27 January 2021
Fact sheet

RTS,S malaria vaccine implementation in Ghana

Published 14 May 2019
Fact sheet

RTS,S malaria vaccine implementation in Malawi

Published 13 May 2019
Fact sheet

10 Tips for Successful Malaria Vaccine Advocacy

PATH
Published 10 October 2012
Fact sheet

Evaluation technologies – Generating reliable data for decision-making

Published 20 April 2016
Fact sheet

RTS,S malaria vaccine frequently asked questions (FAQs)

Published 17 September 2019
Fact sheet

Pages

  • 1
  • 2
  • 3
  • next ›
  • last »

PATH Washington DC

455 Massachusetts Avenue NW, Suite 1000

Washington, DC 20001 | USA 

Tel: 202.822.0033

Fax: 202.457.1466

Email: mvi_info [at] path.org

PATH Headquarters

2201 Westlake Avenue, Suite 200

Seattle, WA 98121 | USA 

Tel: 206.285.3500

Fax: 206.285.6619

Email: info [at] path.org

Website: www.path.org

Follow us

Mail
Twitter
  • Privacy policy
  • Copyright policy
  • Terms of use
© 2023 PATH
Website by Manta Ray Media